Search Results
Oct 15, 2025, 10:00 ET Nikon Small World Honors 51st Annual Photomicrography Competition
Andrew Moore, PhD, Postdoctoral Scientist in the Lippincott-Schwartz Lab at the Howard Hughes Medical Institute's Janelia Research Campus Liz Roth-Johnson, PhD, Curator of Life Sciences at the California Science
More news about: Nikon Instruments Inc.
Oct 15, 2025, 10:00 ET Metastatic Brain Tumor Collaborative Announces First-Ever Collaborative Grant Opportunity Focused on CNS Metastasis
and larger-scale funding. "Metastatic brain tumors are devastating, and yet, historically overlooked," said Nicole Willmarth, PhD, Chief Mission Officer of the American Brain Tumor Association. "This groundbreaking collaborative grant program, led by the ABTA and made possible through
More news about: American Brain Tumor Association
Oct 15, 2025, 09:15 ET Harrington Discovery Institute at University Hospitals and Case Western Reserve School of Medicine Open Call for 2026 Harrington-MSTP Scholar Award
Grant award provides MD/PhD candidates with funding and expertise to translate promising scientific discoveries into medicines CLEVELAND,
More news about: Harrington Discovery Institute
Oct 15, 2025, 08:45 ET Cellular Immunotherapy Breakthroughs Fuel $370 Billion Market Surge
to present additional Phase 1 data demonstrating givastomig's monotherapy activity and engage with the oncology community," said Phillip Dennis, MD, PhD, Chief Medical Officer of I-Mab. "These data support our Phase 2 strategy to combine givastomig with standard of care in first line GEC patients
More news about: Equity Insider
Oct 15, 2025, 08:34 ET TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research
"Researchers need confidence that the data they use will stand up to peer review and drive meaningful insights," said Jeffrey Brown, PhD, Chief Scientific Officer at TriNetX. "The fact that TriNetX is now the most cited real-world dataset reflects not just our scale and quality, but the
More news about: TriNetX
Oct 15, 2025, 08:34 ET TriNetX Becomes the Most Cited Real-World Data Source in Peer-Reviewed Research
"Researchers need confidence that the data they use will stand up to peer review and drive meaningful insights," said Jeffrey Brown, PhD, Chief Scientific Officer at TriNetX. "The fact that TriNetX is now the most cited real-world dataset reflects not just our scale and quality, but the
More news about: TriNetX
Oct 15, 2025, 08:00 ET Hand to Hold to Host Annual National NICU Mental Health Conference
and loss. Keynote speakers include: Sheehan Fisher, PhD: Sheehan Fisher, PhD, is an Associate Professor and perinatal clinical psychologist at Northwestern University, Feinberg School of Medicine and the Associate
More news about: Hand to Hold
Oct 15, 2025, 08:00 ET Koya Medical Honored by Goldman Sachs for Entrepreneurship
Oct. 15, 2025 /PRNewswire/ -- Today, Goldman Sachs (NYSE: GS) is recognizing Koya Medical ("Koya") CEO Andy Doraiswamy, PhD as one of the Most Exceptional Entrepreneurs of 2025 at its Builders and Innovators Summit in Healdsburg, California.
More news about: Koya Medical
Oct 15, 2025, 08:00 ET Monod Bio Receives Award to Develop a New Diagnostic Test for Preeclampsia using AI-designed Proteins
"Preeclampsia remains a silent crisis in many parts of the world, and timely diagnosis is the first step to saving lives," said Daniel Silva Manzano, PhD, CEO of Monod Bio. "With this support, we can apply our de novo protein design platform to create a diagnostic solution that is not just highly sensitive
More news about: Monod Bio
Oct 15, 2025, 08:00 ET OncoHost to Present New Research on Plasma Proteomics-Based Treatment Selection in Melanoma at ESMO 2025
"Selecting the right treatment modality for melanoma patients remains a significant clinical challenge," said Michal Harel, PhD, VP Translational Medicine at OncoHost. "Our findings demonstrate how plasma proteomics can provide actionable insights that inform treatment decisions
More news about: OncoHost
Oct 15, 2025, 07:00 ET Tagworks Pharmaceuticals Announces CTA Authorization and Initiation of Phase 0/1 Clinical Trial for TGW211, a Radiopharmaceutical for the Treatment of HER2+ Tumors
second clinical trial this year mark a major milestone for Tagworks and validate the potential of our Click-to-Release platform," said Marc Robillard, PhD, Chief Scientific Officer and Co-Founder of Tagworks. "Unlike peptides, radiolabeled monoclonal antibodies avoid high radiation doses in the kidney.
More news about: Tagworks Pharmaceuticals BV
Oct 15, 2025, 07:00 ET Tagworks Pharmaceuticals Announces CTA Authorization and Initiation of Phase 0/1 Clinical Trial for TGW211, a Radiopharmaceutical for the Treatment of HER2+ Tumors
second clinical trial this year mark a major milestone for Tagworks and validate the potential of our Click-to-Release platform," said Marc Robillard, PhD, Chief Scientific Officer and Co-Founder of Tagworks. "Unlike peptides, radiolabeled monoclonal antibodies avoid high radiation doses in the kidney.
More news about: Tagworks Pharmaceuticals BV
Oct 15, 2025, 07:00 ET Urano Energy Defines Historical Uranium Inventory at Green River Project in Utah; Evaluation Identifies 1.4 Million Pounds of Historical Indicated and Inferred Uranium Resources
Person The technical information in this news release has been reviewed and approved by Dr. Douglas Underhill, PhD (Geology), MBA, CPG, a Director of Urano Energy Corp. and a Qualified Person as defined by National Instrument 43-101 Standards of Disclosure for
More news about: Urano Energy Corp.
Oct 15, 2025, 06:23 ET Celleste Bio™ Announces Major Milestone for Cocoa Industry: Production of First Chocolate Grade Cocoa Butter Using Cell Cultured Technology
Celleste Bio is a cocoa tech company established in 2022 by Co-founder and Chief Technical Officer Hanne Volpin, PhD, Orna Harel, Avishay Levy and Daphna Michaeli, PhD with support from The Trendlines Group. Its mission is to create an economically and environmentally sustainable cocoa supply.
More news about: Celleste Bio
Oct 15, 2025, 06:23 ET Celleste Bio™ Announces Major Milestone for Cocoa Industry: Production of First Chocolate Grade Cocoa Butter Using Cell Cultured Technology
Celleste Bio is a cocoa tech company established in 2022 by Co-founder and Chief Technical Officer Hanne Volpin, PhD, Orna Harel, Avishay Levy and Daphna Michaeli, PhD with support from The Trendlines Group. Its mission is to create an economically and environmentally sustainable cocoa supply.
More news about: Celleste Bio
Oct 15, 2025, 06:05 ET Forbes Tate Partners Expands Public Affairs and Advocacy Footprint to the Lone Star State
quantify policymaking outcomes, contextualize conversations, and connect dots for public-sector and private-sector executives," said Doug Usher, PhD, partner and insights practice leader at FTP. "Our one-of-a-kind insights platform offers decisionmakers a resource to improve business outcomes
More news about: Forbes Tate Partners
Oct 15, 2025, 06:00 ET Global Wellness Summit Unveils Packed 3-Day Agenda for 2025 Conference in Dubai, November 18-21
chairman and CEO of Therme Group, will join Nancy Davis to discuss "Democratizing Wellness on an Unimaginable Scale," and Meng-Mei Chen, PhD, assistant professor of marketing at École hôtelière de Lausanne, will address the "perfect storm" facing hospitality—societal shifts, talent shortages,
More news about: Global Wellness Summit
Oct 15, 2025, 04:04 ET Indiens Institut Nr. 1, IIT Madras, und eine dänische Universität entdecken genetische „Schalter", die die Krankheitsforschung revolutionieren könnten
zusammenwirken, um komplexe Phänotypen zu modifizieren und zu verbessern. Die Studie wurde von Herrn Srijith Sasikumar, einem PhD-Studenten, und Prof. Himanshu Sinha vom Fachbereich Biotechnologie des IIT Madras in Zusammenarbeit mit Dr. Shannara Taylor Parkins und Dr. Suresh Sudarsan
More news about: IIT Madras
Oct 14, 2025, 23:00 ET HistoIndex to debut FibroSIGHT™ Plus and showcase latest scientific findings at AASLD The Liver Meeting® 2025
clinical trials, into everyday clinical care - enabling more precise liver diagnostics and better outcomes for MASH patients." said Dr. Yukti Choudhury, PhD - Chief Development Officer at HistoIndex. Furthermore, HistoIndex maintains a strong scientific presence at TLM 2025, showcasing
More news about: Histoindex Pte. Ltd.
Oct 14, 2025, 17:03 ET New Book: Experiencing Transcendence Reimagines Addiction and Trauma Recovery -- Moving Beyond Lifelong Struggle to True Freedom
Addiction Recovery Expert Richard Taite and Constance Scharff, PhD, Introduce a Sixth Stage of Recovery With Practical Tools for Post-Traumatic Growth LOS
More news about: AHPR, INC.
Oct 14, 2025, 16:05 ET Illumina to Announce Third Quarter 2025 Financial Results on Thursday, October 30, 2025
close of market on Thursday, October 30, 2025. On the same day, at 1:30 pm Pacific Time (4:30 pm Eastern Time) Jacob Thaysen, PhD, Chief Executive Officer, and Ankur Dhingra, Chief Financial Officer, will host a conference call with analysts, investors, and other interested parties
More news about: Illumina, Inc.
Oct 14, 2025, 13:15 ET MNA Board of Directors Selects Longtime Labor Leader and Dedicated Healthcare Advocate Joe-Ann Fergus, RN, PhD, as Next Executive Director
Oct. 14, 2025 /PRNewswire/ -- The elected Massachusetts Nurses Association (MNA) Board of Directors have announced that Joe-Ann Fergus, RN, PhD, has been appointed the next Executive Director of the Commonwealth's largest healthcare union of nurses and healthcare professionals. Fergus has held
More news about: Massachusetts Nurses Association
Oct 14, 2025, 12:00 ET Unlikely Collaborators Presents: "Living and Working in the Age of AI" with Alexandra Samuel, PhD
livestreamCost: Free (registration required) About Alexandra Samuel, PhD Alexandra Samuel, PhD, is a leading expert on the future of work, showing organizations how to create more effective, inclusive, and satisfying
More news about: Unlikely Collaborators
Oct 14, 2025, 11:51 ET Meridian Bioscience Appoints New CEO and Executive Team to Accelerate Global Growth
Harald Ottenhoff Appointed Executive Vice President, Life Science Harald Ottenhoff, PhD, has been promoted to Executive Vice President, Life Science, succeeding Dr. Lourdes Weltzien, who retired in August 2025 after almost two decades of
More news about: Meridian Bioscience, Inc.
Oct 14, 2025, 09:00 ET Carolina Molecular Selected as Certified Service Provider for CS Genetics' Single-Cell Sequencing Platform
experience and abilities that the Carolina Molecular team brings in sequencing and bioinformatic analysis is a great fit for our technology," Bill Colston, PhD, CEO of CS Genetics, stated. "Translational researchers are tired of the high costs of experiments and instrumentation that's required to run meaningful
More news about: CS Genetics